Renal injury in CKD involves mechanisms in which mineralocorticoid receptor (MR) overactivation, elevated fibroblast growth factor 23 (FGF23), and Klotho insufficiency act together to accelerate kidney damage. The gene discussed is NR3C2; the disease is chronic kidney disease.